儿童伏立康唑治疗药物监测:侵袭性真菌感染治疗与预防经验
该研究在237例儿童患者中采用经验证的高效液相色谱-质谱法测定给药间隔末血浆伏立康唑浓度,其中83例接受静脉给药、154例口服给药。结果显示个体间变异大,剂量与血药暴露正相关;静脉给药者中血清肌酐较高者浓度较高,药物暴露与年龄正相关,男性中位浓度高于女性(P < 0.001)。作者认为密切的药代动力学监测有助于儿童抗真菌治疗个体化。
要点
- 儿童伏立康唑血药浓度个体间变异大,应密切监测药代动力学。
- 静脉给药时血清肌酐较高者伏立康唑浓度较高,需关注肾功能。
- 男性儿童伏立康唑中位血药浓度高于女性(P < 0.001)。
核心结论
- 儿童伏立康唑血药浓度个体间变异大,密切的药代动力学监测应有助于个体化抗真菌治疗。
研究设计与样本
- 单中心经验描述性研究,纳入237例儿童,83例接受静脉伏立康唑、154例接受口服伏立康唑。
- 采用经验证的高效液相色谱-质谱法测定给药间隔末血浆伏立康唑浓度。
主要发现
- 伏立康唑血药浓度呈现较高的个体间变异。
- 药物剂量与血浆药物暴露呈正相关。
- 静脉给药患者中,血清肌酐较高者伏立康唑浓度较高;药物暴露与年龄呈正相关。
- 性别显著影响药物浓度,男性中位药物浓度高于女性(P < 0.001)。
临床怎么用
- 对儿童侵袭性真菌感染的治疗与预防,可考虑开展伏立康唑血药浓度监测以辅助个体化用药。
- 静脉给药且血清肌酐较高的儿童应关注伏立康唑浓度升高。
- 解读儿童伏立康唑浓度时需考虑年龄与性别对暴露的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Voriconazole therapeutic drug monitoring is not consistently recommended due to its high interpatient and intrapatient variability. Here, we aimed to describe our experience with voriconazole for treatment and prophylaxis of invasive fungal infections in paediatric patients. A fully validated high-performance liquid chromatography-mass spectrometry method was used to quantify voriconazole concentration in plasma, at the end of dosing interval. A high interindividual variability was shown. We enrolled 237 children, 83 receiving intravenous and 154 oral voriconazole. A positive correlation between drug dose and drug plasma exposure was observed. Considering intravenous route, patients with higher serum creatinine had higher voriconazole concentrations; a positive correlation was found among drug exposure and age. Sex significantly influenced drug levels: males had higher median drug concentrations than females (P < 0.001). Close voriconazole pharmacokinetics monitoring should help individualize antifungal therapy for children.
引用
- Allegra S, Fatiguso G, De Francia S, et al. Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. Br J Clin Pharmacol. 2017. PMID: 28805964. doi:10.1111/bcp.13401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。